Ledger.Open graph →
SEC Form D · filed July 17, 2012

Carmot Therapeutics Inc

Offering
$1.2M
Sold
$500K
Exemption
—
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

People & firms on this filing (7)

Daniel A. Erlanson · San Francisco, CAExec · DirectorStig K. Hansen · San Francisco, CAExec · DirectorJames A. Huang · Warrington, PADirectorMark H. Handfelt · Seattle, WADirectorJames T. Hayhurst · SAANICHTON, British Columbia, CanadaExec · DirectorRichard Shipley · POWELL RIVER, British Columbia, CanadaExec · DirectorDave Goeddel · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗